A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

M Freedman; A Bar-Or; J Oger; A Traboulsee; D Patry; C Young; S Rainesalo; T Olsson; D Li; A-K Parkkila; H-P Hartung; M Raunio; M Krantz; M Ukkonen; L Ferenczi; T Verco; Johanna Palmio

doi:10.1212/wnl.0b013e318233b240

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

M Freedman, A Bar-Or, J Oger, A Traboulsee, D Patry, C Young, S Rainesalo, T Olsson, D Li, A-K Parkkila, H-P Hartung, M Raunio, M Krantz, M Ukkonen, L Ferenczi, T Verco, Johanna Palmio

Research output: Contribution to journal › Article › Scientific › peer-review

115 Citations (Scopus)

Original language	English
Pages (from-to)	1551-1560
Journal	Neurology
Volume	77
Issue number	16
DOIs	https://doi.org/10.1212/wnl.0b013e318233b240
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

Access to Document

10.1212/wnl.0b013e318233b240

Cite this

Freedman, M., Bar-Or, A., Oger, J., Traboulsee, A., Patry, D., Young, C., Rainesalo, S., Olsson, T., Li, D., Parkkila, A.-K., Hartung, H.-P., Raunio, M., Krantz, M., Ukkonen, M., Ferenczi, L., Verco, T., & Palmio, J. (2011). A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. Neurology, 77(16), 1551-1560. https://doi.org/10.1212/wnl.0b013e318233b240

@article{1f29c2b43b5848ee9aae0bd1ba2fce1d,

title = "A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS",

author = "M Freedman and A Bar-Or and J Oger and A Traboulsee and D Patry and C Young and S Rainesalo and T Olsson and D Li and A-K Parkkila and H-P Hartung and M Raunio and M Krantz and M Ukkonen and L Ferenczi and T Verco and Johanna Palmio",

year = "2011",

doi = "10.1212/wnl.0b013e318233b240",

language = "English",

volume = "77",

pages = "1551--1560",

journal = "Neurology",

issn = "0028-3878",

publisher = "American Academy of Neurology",

number = "16",

}

Freedman, M, Bar-Or, A, Oger, J, Traboulsee, A, Patry, D, Young, C, Rainesalo, S, Olsson, T, Li, D, Parkkila, A-K, Hartung, H-P, Raunio, M, Krantz, M, Ukkonen, M, Ferenczi, L, Verco, T & Palmio, J 2011, 'A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS', Neurology, vol. 77, no. 16, pp. 1551-1560. https://doi.org/10.1212/wnl.0b013e318233b240

TY - JOUR

T1 - A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS

AU - Freedman, M

AU - Bar-Or, A

AU - Oger, J

AU - Traboulsee, A

AU - Patry, D

AU - Young, C

AU - Rainesalo, S

AU - Olsson, T

AU - Li, D

AU - Parkkila, A-K

AU - Hartung, H-P

AU - Raunio, M

AU - Krantz, M

AU - Ukkonen, M

AU - Ferenczi, L

AU - Verco, T

AU - Palmio, Johanna

PY - 2011

Y1 - 2011

U2 - 10.1212/wnl.0b013e318233b240

DO - 10.1212/wnl.0b013e318233b240

M3 - Article

SN - 0028-3878

VL - 77

SP - 1551

EP - 1560

JO - Neurology

JF - Neurology

IS - 16

ER -